Hüppe M, Maier C, Gockel H, Zenz M, Frettlöh J
Klinik für Anästhesiologie, Universität zu Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Deutschland.
Schmerz. 2011 Feb;25(1):77-88. doi: 10.1007/s00482-010-0999-7.
More than 10 years ago Gerbershagen gave a pessimistic prognosis for treatment success in patients with higher stages of pain chronification. To date only few studies concerning this statement exist and the results are inconsistent. The objective of this study was to evaluate the prognostic validity of the Mainz pain staging system (MPSS) in a large multicenter sample. It was assessed whether effects of treatment in patients with higher stages of pain chronification are less than those in other patients. Of further interest was whether treatment success is related to different outcome measures.
A total of 1,461 patients with the pain syndromes headache, neuropathic pain, back pain or algiomuscular pain and arthralgia were enrolled in the analysis. They were selected from the QUAST analysis sample which includes patients from 19 cooperating pain clinics. All patients had completed the German pain questionnaire prior to pain treatment and these data were compared with the last available questionnaire during the course of treatment. Outcome measures were pain intensity, psychological disability scores and patient global impression of success (PGIS).
Analysis showed a significant improvement of all outcome measures in every MPSS stage. The greatest improvement was noted for pain intensity whereas outcome variables regarding mental health revealed the lowest improvement. Compared with patients with low pain chronification, changes in pain intensity were smaller for patients with the highest MPSS stage III but even in these patients the strength of effect was more than 0.80. About 50% of all patients showed a reduction of pain intensity of 2 or more points on an 11 point numerical rating scale and 46.6% of patients with a MPSS stage III showed this improvement. Importantly, PGIS was independent of the stage of chronification. Nearly 45% of all patients evaluated the treatment success as good or very good.
According to the view of the patients, treatment in specialized pain centres is successful even in the highest stage of pain chronification. This notwithstanding, success of treatment must not be confounded with the efficacy of an intervention. It has to be noted that the results of the current study do not allow conclusions regarding efficacy of treatment.
10多年前,格伯沙根对疼痛慢性化程度较高阶段患者的治疗成功率给出了悲观的预后判断。迄今为止,关于这一说法的研究很少,且结果不一致。本研究的目的是在一个大型多中心样本中评估美因茨疼痛分期系统(MPSS)的预后有效性。评估疼痛慢性化程度较高阶段患者的治疗效果是否低于其他患者。另一个关注点是治疗成功是否与不同的结局指标相关。
共有1461例患有头痛、神经性疼痛、背痛或肌痛性疼痛以及关节痛等疼痛综合征的患者纳入分析。他们选自QUAST分析样本,该样本包括来自19个合作疼痛诊所的患者。所有患者在疼痛治疗前均完成了德国疼痛问卷,这些数据与治疗过程中最后一份可用问卷进行了比较。结局指标包括疼痛强度、心理残疾评分和患者总体成功印象(PGIS)。
分析显示,每个MPSS阶段的所有结局指标均有显著改善。疼痛强度的改善最为明显,而心理健康方面的结局变量改善最小。与疼痛慢性化程度低的患者相比,MPSS最高的III期患者疼痛强度的变化较小,但即使在这些患者中,效应强度也超过0.80。在11分数字评分量表上,约50%的患者疼痛强度降低了2分或更多,MPSS III期患者中有46.6%表现出这种改善。重要的是,PGIS与慢性化阶段无关。近45%的患者将治疗成功评价为良好或非常好。
从患者的角度来看,即使在疼痛慢性化的最高阶段,专科疼痛中心的治疗也是成功的。尽管如此,治疗的成功不能与干预的疗效相混淆。必须指出,本研究结果无法得出关于治疗疗效的结论。